These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27363857)

  • 1. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
    Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
    Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study.
    Blaszczyk E; Lim C; Kellman P; Schmacht L; Gröschel J; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2021 Nov; 23(1):130. PubMed ID: 34743704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
    Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy.
    Leali M; Aimo A; Ricci G; Torri F; Todiere G; Vergaro G; Grigoratos C; Giannoni A; Aquaro GD; Siciliano G; Emdin M; Passino C; Barison A
    J Cardiovasc Med (Hagerstown); 2023 Jun; 24(6):340-347. PubMed ID: 37129928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute impact of an endurance race on cardiac function and biomarkers of myocardial injury in triathletes with and without myocardial fibrosis.
    Tahir E; Scherz B; Starekova J; Muellerleile K; Fischer R; Schoennagel B; Warncke M; Stehning C; Cavus E; Bohnen S; Radunski UK; Blankenberg S; Simon P; Pressler A; Adam G; Patten M; Lund GK
    Eur J Prev Cardiol; 2020 Jan; 27(1):94-104. PubMed ID: 31242053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy.
    Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS
    Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction.
    Greulich S; Kitterer D; Latus J; Aguor E; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Mayr A; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Myocardial Fibrosis on Left Ventricular Function Evaluated by Feature-Tracking Myocardial Strain Cardiac Magnetic Resonance in Competitive Male Triathletes With Normal Ejection Fraction.
    Tahir E; Starekova J; Muellerleile K; Freiwald E; von Stritzky A; Münch J; Avanesov M; Weinrich JM; Stehning C; Cavus E; Bohnen S; Radunski UK; Blankenberg S; Adam G; Simon P; Pressler A; Patten M; Lund GK
    Circ J; 2019 Jun; 83(7):1553-1562. PubMed ID: 31080228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
    Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement.
    Spartera M; Damascelli A; Mozes F; De Cobelli F; La Canna G
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1351-1360. PubMed ID: 28299606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.
    Rosales XQ; Moser SJ; Tran T; McCarthy B; Dunn N; Habib P; Simonetti OP; Mendell JR; Raman SV
    J Cardiovasc Magn Reson; 2011 Aug; 13(1):39. PubMed ID: 21816046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Bui AH; Roujol S; Foppa M; Kissinger KV; Goddu B; Hauser TH; Zimetbaum PJ; Ngo LH; Manning WJ; Nezafat R; Delling FN
    Heart; 2017 Feb; 103(3):204-209. PubMed ID: 27515954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
    Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.
    Chmielewski L; Bietenbeck M; Patrascu A; Rösch S; Sechtem U; Yilmaz A; Florian AR
    Clin Res Cardiol; 2019 Aug; 108(8):857-867. PubMed ID: 30767060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.